[Characteristics of antibiotic use in children]

Insights

Pediatric antibiotic therapy requires careful consideration of bacteriological findings and drug pharmacokinetics. Dosing must account for children

Area of Science:

  • Pediatric Pharmacology
  • Infectious Diseases
  • Clinical Pharmacy

Background:

  • Antibiotic selection and dosing in children are complex.
  • Limited antibiotic elimination in neonates necessitates careful management.
  • Antibiotics cross the placental barrier and are present in breast milk.

Purpose of the Study:

  • To review key considerations for antibiotic therapy in pediatric patients.
  • To highlight factors influencing antibiotic pharmacokinetics and toxicity in children.
  • To discuss the implications of antibiotic use on pediatric health outcomes.

Main Methods:

  • Literature review of pediatric antibiotic pharmacokinetics and pharmacodynamics.
  • Analysis of factors affecting antibiotic elimination and toxicity in children.
  • Synthesis of current recommendations for antibiotic use in pediatric populations.

Main Results:

  • Antibiotic elimination is significantly reduced in the early postnatal period, correlating with gestational age.
  • Children exhibit heightened sensitivity to the direct toxic effects of antibiotics.
  • Dysbacteriosis and diverse allergic reactions are common adverse events in pediatric patients.

Conclusions:

  • Bacteriological findings are crucial for guiding pediatric antibiotic therapy.
  • Antibiotic dosing must be individualized based on pharmacokinetics, organ function, and drug properties.
  • While combined therapy can be effective, monotherapy is often preferred due to reduced toxicity concerns.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...